APOE and familial hypercholesterolemia: In one study, long-term treatment with bone marrow-derived EPCs from young non-atherosclerotic Apolipoprotein E (ApoE) knockout mice prevented atherosclerosis progression in ApoE knockout recipients despite persistent hypercholesterolemia [2].